INTRODUCTION
THYRONORM 125MCG TABLET contains Thyroxine which belongs to the group of medicines called Thyroid hormone receptors. It is used as a replacement therapy in the treatment of primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.
It is also used as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated papillary or follicular carcinoma (a differentiated thyroid cancer where cancer develops from the follicular cells and grow slowly) of thyroid gland.
Hypothyroidism is a condition in which the thyroid gland doesn't produce enough thyroid hormone in the blood stream. It is characterized by symptoms such as weakness, increased sensitivity to cold, constipation, dry skin, weight gain, puffy face, hoarseness and muscle weakness.
THYRONORM 125MCG TABLET is not recommended for use if you had a heart attack, acute myocarditis (inflammation/swelling of the heart muscle) or acute pancarditis (general inflammation/ swelling of the heart) recently.
Before taking this medicine, inform your doctor if you are having severe liver disease such as liver cirrhosis, kidney problems such as renal impairment, end-stage renal disease, nephrotic syndrome, renal failure, other heart problems, history of heart attack and/or history of kidney transplant.
It is not recommended for use in patients with overactive thyroid gland or untreated adrenal insufficiency (inability of adrenal glands to make enough of the hormone cortisol).
THYRONORM 125MCG TABLET should be used with caution in pregnant and breastfeeding women. It should be used with caution in children and adolescents (aged below 18 years) and elderly patients (aged above 65 years).
The most common side effects associated with the use of THYRONORM 125MCG TABLET are skin rash, itching and mild leucopenia (reduced white blood cell count). Consult your doctor if any of these symptoms worsens.
USES OF THYRONORM 125MCG TABLET
Treats primary, secondary and tertiary congenital or acquired hypothyroidism.
To manage thyrotropin-dependent well-differentiated papillary or follicular carcinoma of thyroid gland (with adjunct to surgery and radioiodine therapy)
SIDE EFFECTS OF THYRONORM 125MCG TABLET
COMMON
Skin rash
Itching
Mild leucopenia (reduced white blood cell count)
UNCOMMON
Signs of agranulocytosis (deficiency of certain white blood cells) such as increased vulnerability to infection
RARE
Hair loss
Seizures (fits)
Stop taking THYRONORM 125MCG TABLET and contact your doctor if you experience any of the following side effects:
Signs of heart problems such as chest pain, rapid/irregular heartbeat, pounding heartbeat and shortness of breath
Signs of heart attack such as crushing chest pain that radiates to the left arm and/or jaw, sweating, nausea, vomiting and shortness of breath
Signs of serious allergic reactions such as rash, raised red patches, swelling of the face, lips, tongue, or throat and difficulty swallowing or breathing
Signs of seizure (fits) such as muscle twitching, changes in emotions, confusion or loss of consciousness with uncontrollable shaking
Signs of increased pressure in the brain (in children) such as headaches, vison problems or complete loss of vision, double vision, ringing in the ears or pain in the arms
Signs of slipped capital femoral epiphysis (condition marked by weakened hip joint in children) such as stiffness/pain in the knee or groin, walking with a limp, inability to bear weight on the affected side.
Signs of osteoporosis (condition marked by decreased bone density) such as back pain, loss of height over time, stooped posture, broken bones
